paclitaxel,CTX-009
Compass Therapeutics
[]
$cmpx compass therapeutics announces that the phase 2 data of ctx-009 in combination with paclitaxel in patients with biliary tract cancers (btc) will be presented at the asco gi cancers symposium on january 20, 2023 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).